Liliana Szuber-Lykowska

Przybyszewskiego Street 49
Poznan, WP 60355, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Multicentre retrospective real-world evidence study evaluating the effectiveness and safety of mirikizumab in patients with moderately to severely active ulcerative colitis.

Multicentre retrospective real-world evidence study evaluating the effectiveness and safety of mirikizumab in patients with moderately to severely active ulcerative colitis.

Journal: Przeglad gastroenterologiczny

Published: March 30, 2026

Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?

Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: February 09, 2026

RESCUE-CD - Real-world effectiveness of risankizumab in moderate-to-severe Crohn's disease: a case series involving the most refractory and challenging patients.

RESCUE-CD - Real-world effectiveness of risankizumab in moderate-to-severe Crohn's disease: a case series involving the most refractory and challenging patients.

Journal: Przeglad gastroenterologiczny

Published: January 08, 2026

Inflammatory bowel diseases and the low-FODMAP diet: benefits and challenges in therapy.

Inflammatory bowel diseases and the low-FODMAP diet: benefits and challenges in therapy.

Journal: Frontiers in nutrition

Published: July 26, 2025

Apoptosis and inflammatory genes variants in primary non-response to anti-TNF therapy in Crohn's disease patients.

Apoptosis and inflammatory genes variants in primary non-response to anti-TNF therapy in Crohn's disease patients.

Journal: European journal of gastroenterology & hepatology

Published: August 14, 2023

Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patients.

Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patients.

Journal: Journal of applied genetics

Published: August 07, 2023

Association of the ILR1 and FAS gene variants with primary nonresponse to anti-tumor necrosis factor therapy in patients with Crohn disease.

Association of the ILR1 and FAS gene variants with primary nonresponse to anti-tumor necrosis factor therapy in patients with Crohn disease.

Journal: Polish archives of internal medicine

Published: March 14, 2023

Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury.

Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury.

Journal: International journal of environmental research and public health

Published: January 20, 2023

Why Does Obesity as an Inflammatory Condition Predispose to Colorectal Cancer?

Why Does Obesity as an Inflammatory Condition Predispose to Colorectal Cancer?

Journal: Journal of clinical medicine

Published: December 31, 2022

Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.

Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.

Journal: Nutrients

Published: May 19, 2022

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease.

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease.

Journal: Toxics

Published: February 11, 2022

Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)-A Narrative Review.

Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)-A Narrative Review.

Journal: Journal of clinical medicine

Published: October 07, 2021

Showing 1-12 of 53

Last Updated: 09/26/2026